Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

被引：0
|
作者：
Xiao-Bing Yang
Wan-yin Wu
Shun-qin Long
Hong Deng
Zong-Qi Pan
Wen-Feng He
Yu-Shu Zhou
Gui-Ya Liao
Qiu-Ping Li
Shu-Jing Xiao
Jiao-Zhi Cai
机构：
[1] Guangdong Provincial Hospital of Traditional Chinese Medicine,Department of Oncology
来源：
Trials | / 16卷
关键词：
Non-small cell lung cancer; Chinese herbal medicine; decoction; Gefitinib; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effect of epidermal growth factor receptor gene mutations on adverse events of gefitinib in patients with non-small cell lung cancer.
    Fujiwara, Y
    Kiura, K
    Toyooka, S
    Aoe, M
    Tabata, M
    Hosokawa, S
    Kozuki, T
    Date, H
    Ueoka, H
    Tanimoto, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 644S - 644S
  • [22] THE EFFECT OF GEFITINIB IN PATIENTS WITH POSTOPERATIVE RECURRENT NON-SMALL CELL LUNG CANCER HARBOURING MUTATIONS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR.
    Ko, Ryo
    Kenmotsu, Hirotsugu
    Hisamatsu, Yasushi
    Akamatsu, Hiroaki
    Omori, Shota
    Nakashima, Kazuhisa
    Oyakawa, Takuya
    Wakuda, Kazushige
    Imai, Hisao
    Ono, Akira
    Taira, Tetsuhiko
    Murakami, Haruyasu
    Naito, Tateaki
    Mori, Keita
    Endo, Masahiro
    Takahashi, Toshiaki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S869 - S869
  • [23] Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
    Guo Jian
    Zhou Songwen
    Zhang Ling
    Deng Qinfang
    Zhang Jie
    Tang Liang
    Zhou Caicun
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1341 - 1347
  • [24] Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
    Guo Jian
    Zhou Songwen
    Zhang Ling
    Deng Qinfang
    Zhang Jie
    Tang Liang
    Zhou Caicun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (09) : 1341 - 1347
  • [25] Update on epidermal growth factor receptor mutations in non-small cell lung cancer
    Riely, Gregory J.
    Politi, Katerina A.
    Miller, Vincent A.
    Pao, William
    CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7232 - 7241
  • [26] Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations
    Yoon, Shinkyo
    Lee, Dae Ho
    Kim, Sang-We
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (01)
  • [27] Epidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patients
    Lin Li
    Zijin Zhang
    Zhixin Bie
    Zheng Wang
    Ping Zhang
    Xin Nie
    Yuanming Li
    Hui Wang
    Bin Ai
    Gang Cheng
    ChineseJournalofCancerResearch, 2015, 27 (03) : 294 - 300
  • [28] Epidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patients
    Li, Lin
    Zhang, Zijin
    Bie, Zhixin
    Wang, Zheng
    Zhang, Ping
    Nie, Xin
    Li, Yuanming
    Wang, Hui
    Ai, Bin
    Cheng, Gang
    CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (03) : 294 - 300
  • [29] Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer
    Gregorc, V
    Ceresoli, GL
    Floriani, I
    Spreafico, A
    Bencardino, KB
    Ludovini, V
    Pistola, L
    Mihaylova, Z
    Tofanetti, FR
    Ferraldeschi, M
    Torri, V
    Cappuzzo, F
    Crinò, L
    Tonato, M
    Villa, E
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6006 - 6012
  • [30] EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS IN BULGARIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Bichev, S.
    Marinova, D. M.
    Slavova, Y.
    Savov, A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S16 - S16
12345